Gambling Disorder: Diagnosis and Treatment

Donna M. Kaminski, DO, MPH
Heli Naik, DO
Doreen Sperber Weiss, APN, PhD

American Family Physician. 2026;113(6):536-541.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Pathologic gambling, also known as gambling disorder, is a behavioral addiction. The prevalence of gambling disorder has increased in recent years as gambling has become more accessible. Gambling disorder is often underdiagnosed and may have disabling effects on patients. Although men are more often affected, the rate of gambling disorder has been increasing in women. Risk factors include comorbid substance use disorder, mental health diagnoses, lower socioeconomic status, and participation in other risky behaviors. The US Preventive Services Task Force has not addressed screening for gambling disorders. In the United Kingdom, the National Institute for Health and Care Excellence has developed a guideline for case-finding based on expert opinion; the guideline suggests asking a direct question, such as “Do you gamble?,” to assess patients for gambling disorder. The Diagnostic and Statistical Manual of Mental Disorders, 5th ed., text revision criteria should be used to confirm the diagnosis and classify severity. Pharmacologic interventions such as naltrexone or olanzapine may reduce symptom severity in the short-term, although more study is needed. Psychotherapy, including cognitive behavior therapy and motivational interviewing, offers short-term benefits; however, its long-term effectiveness is uncertain. Self-help and family support groups have limited evidence but provide safe places for affected individuals and loved ones to alleviate the stress associated with the financial and emotional consequences of gambling.

DONNA M. KAMINSKI, DO, MPH, FAAFP, is an assistant director at Rutgers Health Robert Wood Johnson University Hospital Somerset Family Practice Residency Program, Somerville, New Jersey, and a clinical assistant professor in the Department of Family Medicine and Community Health at Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.

HELI NAIK, DO, CAQSM, is an assistant director at Rutgers Health Robert Wood Johnson University Hospital Somerset Family Practice Residency Program, Somerville, and a clinical assistant professor in the Department of Family Medicine and Community Health at Rutgers Robert Wood Johnson Medical School, New Brunswick.

DOREEN SPERBER WEISS, APN, PhD, is a behavioral scientist at Rutgers Health Robert Wood Johnson University Hospital Somerset Family Practice Residency Program, Somerville.

Address correspondence to Donna M. Kaminski, DO, MPH, at donna.kaminski@rwjbh.org.

Author disclosure: No relevant financial relationships.

  1. 1.National Council on Problem Gambling. FAQs: what is problem gambling? Accessed July 22, 2025. ncpgambling.org/help-treatment/faqs-what-is-problem-gambling
  2. 2.Statista. Gambling in the United States–statistics & facts. Accessed September 11, 2025. https://www.statista.com/topics/1368/gambling/#topicOverview
  3. 3.United States General Accounting Office. Impact of gambling: economic effects more measurable than social effects. April 2000. Accessed October 25, 2025. https://www.gao.gov/assets/ggd-00-78.pdf
  4. 4.Van der Maas M, Mann RE, Turner NE, et al. The prevalence of problem gambling and gambling-related behaviors among older adults in Ontario. J Gambl Issues. 2018;39:67-84.
  5. 5.Wong G, Zane N, Saw A, et al. Examining gender differences for gambling engagement and gambling problems among emerging adults. J Gambl Stud. 2013;29(2):171-189.
  6. 6.Shaffer HJ, Hall MN, Vander Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Public Health. 1999;89(9):1369-1376.
  7. 7.Welte JW, Barnes GM, Tidwell MCO, et al. The prevalence of problem gambling among U.S. adolescents and young adults: results from a national survey. J Gambl Stud. 2008;24(2):119-133.
  8. 8.Bowden-Jones H, Hook RW, Grant JE, et al. Gambling disorder in the UK: key research priorities and the urgent need for independent research funding. Lancet Psychiatry. 2022;9(4):321-329.
  9. 9.Gerstein D, Hoffmann J, Larison C, et al. Gambling impact and behavior study. April 1, 1999. Accessed July 21, 2025. https://www.norc.org/content/dam/norc-org/pdfs/GIBSFinalReportApril1999.pdf
  10. 10.National Institute for Health and Care Excellence. Gambling-related harms: identification, assessment and management. NG248. January 28, 2025. Accessed July 21, 2025. https://www.nice.org.uk/guidance/ng248
  11. 11.American Psychiatric Association. What is gambling disorder? May 2024. Accessed June 11, 2025. www.psychiatry.org/patients-families/gambling-disorder/what-is-gambling-disorder
  12. 12.Diagnostic and Statistical Manual of Mental Disorders, 5th ed., text revision. American Psychiatric Association; 2022.
  13. 13.Breyer JL, Botzet AM, Winters KC, et al. Young adult gambling behaviors and their relationship with the persistence of ADHD. J Gambl Stud. 2009;25(2):227-238.
  14. 14.Hollander E, Wong CM. Obsessive-compulsive spectrum disorders. J Clin Psychiatry. 1995;56:3-6, discussion 53–55.
  15. 15.Echeburua E, Amor PJ, Gómez M. Current psychological therapeutic approaches for gambling disorder with psychiatric comorbidities: a narrative review. Salud Mental. 2017;40(6):299-305.
  16. 16.Blanco C, Moreyra P, Nunes EV, et al. Pathological gambling: addiction or compulsion? Semin Clin Neuropsychiatry. 2001;6(3):167-176.
  17. 17.Potenza MN. Should addictive disorders include non-substance– related conditions? Addiction. 2006;101:142-151.
  18. 18.Petry NM, Stinson FS, Grant BF. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66(5):564-574.
  19. 19.Manning V, Dowling NA, Lee S, et al. Problem gambling and substance use in patients attending community mental health services. J Behav Addict. 2017;6(4):678-688.
  20. 20.Lorains FK, Cowlishaw S, Thomas SA. Prevalence of comorbid disorders in problem and pathological gambling: systematic review and meta-analysis of population surveys. Addiction. 2011;106(3):490-498.
  21. 21.Grant JE, Potenza MN, Weinstein A, et al. Introduction to behavioral addictions. Am J Drug Alcohol Abuse. 2010;36(5):233-241.
  22. 22.Dowling N, Merkouris S, Lubman D, et al. Pharmacological interventions for the treatment of disordered and problem gambling. Cochrane Database Syst Rev. 2022(9):CD008936.
  23. 23.Cowlishaw S, Merkouris S, Dowling N, et al. Psychological therapies for pathological and problem gambling. Cochrane Database Syst Rev. 2012(11):CD008937.
  24. 24.Ravindran A, Telner J. Effects of medication and cognitive behavior therapy, alone and in combination, on pathological gambling. Accessed October 25, 2025. https://www.greo.ca/Modules/EvidenceCentre/files/ResSum_Ravindran%20et%20al(2006)Effects_of_medication_and_cognitive_behaviour_therapy.pdf
  25. 25.Littman-Sharp N, Turner NE, Toneatto T. Inventory of gambling situations (IGS): user's guide. 2009. Toronto Center for Addiction and Mental Health. Accessed on October 25, 2025. https://kmb.camh.ca/ggtu/PDF%20library/IGSUserGuide_2009.pdf
  26. 26.Schuler A, Ferentzy P, Turner NE, et al. Gamblers Anonymous as a recovery pathway: a scoping review. J Gambl Stud. 2016;32(4):1261-1278.
  27. 27.Unwin BK, Davis MK, De Leeuw JB. Pathologic gambling. Am Fam Physician. 2000;61(3):741-749.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.